Newsbenzinga
Maze Therapeutics Announces Presentation Of Updated Phase 2 MZE829 Kidney Disease Data At ASN Kidney Week On October 24
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…